GlassScriptPhysician profile
Alvin C Wee
NPI 1558539874
$46,103.93
in general payments reported to CMS, 2019-2025
22 companies · $6,758 in 2025
The $6,758 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $2,588 · 2021: $6,714 · 2022: $21K · 2023: $4,772 · 2024: $4,235 · 2025: $6,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,919 · Food and Beverage: $3,346 · Honoraria: $3,000 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,918.68 |
| Food and Beverage | $3,346.02 |
| Honoraria | $3,000.00 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veloxis Pharmaceuticals, INC. | $33,040.11 | 2020-2023 | Envarsus |
| Globus Medical, INC. | $3,648.46 | 2024 | Alif, Xlif, Excelsiusgps Robotic Navigation System |
| Transmedics, INC. | $3,183.87 | 2025 | Organ Care System |
| Medtronic, INC. | $1,764.88 | 2021-2025 | Aquamantys(Tm), Signia, Endo Gia Ultra |
| Vb Spine LLC | $1,622.52 | 2025 | Spine Guidance Software, Monterey Al, Stryker |
| Dilon Technologies, INC. | $425.19 | 2025 | Hemoblast Bellows |
| Xvivo Perfusion INC. | $389.48 | 2022 | |
| Intuitive Surgical, INC. | $272.83 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $238.69 | 2020 | |
| Ethicon US, LLC | $223.09 | 2019-2025 | Echelon; Endopath, Contour |
| Baxter Healthcare | $197.97 | 2020-2025 | Perclot, Tisseel |
| Integra Lifesciences Corporation | $169.70 | 2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Novartis Pharmaceuticals Corporation | $163.90 | 2019-2023 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Genzyme Corporation | $135.81 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $123.46 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $94.61 | 2019 | |
| Alexion Pharmaceuticals, INC. | $88.64 | 2020 | |
| Paragonix Technologies, INC. | $69.27 | 2025 | Kidneyvault |
| La Jolla Pharmaceutical Company | $56.74 | 2023 | Giapreza |
| Takeda Pharmaceuticals U.S.A., INC. | $35.79 | 2022 | |
| Covidien LP | $21.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alvin Wee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.